Cargando…
Controlled Human Infections As a Tool to Reduce Uncertainty in Clinical Vaccine Development
Vaccines can be extremely cost-effective public health measures. Unfortunately the research and development (R&D) of novel vaccines is suffering from rising costs and declining success rates. Because many vaccines target low- and middle income markets (LMIC), output needs to be maintained at a c...
Autores principales: | Roestenberg, Meta, Kamerling, Ingrid M. C., de Visser, Saco J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215823/ https://www.ncbi.nlm.nih.gov/pubmed/30420951 http://dx.doi.org/10.3389/fmed.2018.00297 |
Ejemplares similares
-
Corrigendum: Controlled Human Infections As a Tool to Reduce Uncertainty in Clinical Vaccine Development
por: Roestenberg, Meta, et al.
Publicado: (2019) -
Assessment of Risks Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Experimental Human Infection Studies
por: Kuiper, Vincent P, et al.
Publicado: (2020) -
How to expedite early‐phase SARS‐CoV‐2 vaccine trials in pandemic setting—A practical perspective
por: van der Plas, Johan L., et al.
Publicado: (2020) -
Money-oriented risk-takers or deliberate decision-makers: a cross-sectional survey study of participants in controlled human infection trials
por: Hoogerwerf, Marie-Astrid, et al.
Publicado: (2020) -
Diagnosis and treatment based on quantitative PCR after controlled human malaria infection
por: Walk, Jona, et al.
Publicado: (2016)